Oric Pharmaceuticals, Inc. — Director's Dealing 2022

Jun 18, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oric Pharmaceuticals, Inc. (ORIC)
CIK: 0001796280
Period of Report: 2022-06-17

Reporting Person: Kunkel Lori Anne (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-17	Stock Option (right to buy)	$3.75	A	53700	Acquired	2032-06-16	Common Stock (53700)	Direct

Footnotes

F1: (A) 20,500 of the shares subject to the option shall vest on the earlier of (i) June 17, 2023 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant, and (B) one thirty-sixth (1/36th) of the remaining 33,200 shares subject to the option shall vest on each monthly anniversary of June 17, 2022.